Security key
71722W107
Phathom Pharmaceuticals, Inc. - Common Stock (PHAT)
CUSIP: 71722W107
Q1 2024 13F Holders as of 31 Mar 2024
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 55,378,949
- Total 13F value
- $588,085,973
- Share change
- +1,266,073
- Put/Call ratio
- 180%
- SEC-reported price per share
- $10.62
- Number of holders
- 112
- Value change
- +$14,631,856
- Number of buys
- 50
- Number of sells
- 51
- Shares outstanding
- 79,611,764
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2024
Institutions
112
Top holders
10
PHAT full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Phathom Pharmaceuticals, Inc. SEC filings
Phathom Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 71722W107
Recent filing periods:
Ownership snapshot
Top reported holders of PHAT - Phathom Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Frazier Life Sciences Man...
Disclosed value leader
Frazier Life Sciences Man...
Comparable rows
15/15
Latest evidence
24 Jan 2024
13F
3/4/5
Lead comparable stake: 13%
Showing 1-6 of 15 holder rows.
Quick read
Frazier Life Sciences Management, L.P. leads the comparable SEC ownership view at 13%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Frazier Life Sciences Management, L.P.'s linked filing trail.
Comparable ownership
Top 5
Frazier Life Sciences Management,...
13%
TAKEDA PHARMACEUTICAL CO LTD
9.4%
Medicxi Ventures Management (Jers...
4.7%
Carlyle Group Inc.
4.4%
Invesco Ltd.
4%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. |
13F
Company
|
13%
|
$92,297,717
10,109,279 shares
|
— | 31 Dec 2023 |
| TAKEDA PHARMACEUTICAL CO LTD |
13F
3/4/5
Company · 10%+ Owner
|
9.4%
|
$77,352,796
7,459,286 shares
|
— | 31 Dec 2023 |
| Medicxi Ventures Management (Jersey) Ltd |
3/4/5
13F
10%+ Owner · Company
|
4.7%
from 13F
|
$60,463,034
7,464,572 shares
|
— | 24 Jan 2024 |
| Carlyle Group Inc. |
13F
Company
|
4.4%
|
$31,925,857
3,496,808 shares
|
— | 31 Dec 2023 |
| Invesco Ltd. |
13F
Company
|
4%
|
$28,920,672
3,167,653 shares
|
— | 31 Dec 2023 |
| BlackRock Finance, Inc. |
13F
Company
|
3.4%
|
$24,458,274
2,678,891 shares
|
— | 31 Dec 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
112
Shares
55,378,949
Rows available
112
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2024 vs Q1 2024 Across Filers
Q1 2024 holders
112
Q1 2024 holders
112
Holder diff
0
| Investor | Q1 2024 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q1 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend